Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 2;25(9):euad282.
doi: 10.1093/europace/euad282.

Does the spatial distribution of atrial arrhythmogenic substrate matter? Insights from the DECAAF II trial

Till F Althoff  1   2 , Andreu Porta-Sanchez  1   2   3
Affiliations
Editorial

Does the spatial distribution of atrial arrhythmogenic substrate matter? Insights from the DECAAF II trial

Till F Althoff et al. Europace. .

Abstract

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: T.F.A. has received research grants for investigator-initiated trials from Biosense Webster. A.P.-S. has received consultant honoraria from Abbott Medical Devices, Biosense Webster, and Boston Scientific.

Figures

Graphical abstract
Graphical abstract
See this image and copyright information in PMC

Comment on

References

    1. Althoff TF, Eichenlaub M, Padilla-Cueto D, Lehrmann H, Garre P, Schoechlin Set al. . Predictive value of late gadolinium enhancement cardiovascular magnetic resonance in patients with persistent atrial fibrillation: dual-centre validation of a standardized method. Eur Heart J Open 2023;3:oeac085. - PMC - PubMed
    1. Caixal G, Alarcón F, Althoff TF, Nuñez-Garcia M, Benito EM, Borràs Ret al. . Accuracy of left atrial fibrosis detection with cardiac magnetic resonance: correlation of late gadolinium enhancement with endocardial voltage and conduction velocity. Europace 2021;23:380–8. - PubMed
    1. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski Fet al. . Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. Jama 2014;311:498–506. - PubMed
    1. Goette A, Auricchio A, Boriani G, Braunschweig F, Terradellas JB, Burri Het al. . EHRA White Paper: knowledge gaps in arrhythmia management-status 2019. Europace 2019;21:993–4. - PubMed
    1. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SAet al. . EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace 2016;18:1455–90. - PMC - PubMed